Alemtuzumab Intravenous and Pentamycetin Ophthalmic Solution 0.25%
Determining the interaction of Alemtuzumab Intravenous and Pentamycetin Ophthalmic Solution 0.25% and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: alemtuzumab
Brand name: Campath, Lemtrada
Synonyms: Alemtuzumab
Generic Name: chloramphenicol ophthalmic
Brand name:
Synonyms: Chloramphenicol (Ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Alemtuzumab Intravenous-Pentamycetin Ophthalmic Solution 0.5%
- Alemtuzumab Intravenous-Pentasa
- Alemtuzumab Intravenous-Pentasa Rectal
- Alemtuzumab Intravenous-Pentazocine
- Alemtuzumab Intravenous-Pentazocine Acetaminophen
- Alemtuzumab Intravenous-Pentazocine and Naloxone
- Pentamycetin Ophthalmic Solution 0.25%-Alenaze-D
- Pentamycetin Ophthalmic Solution 0.25%-Alendronate
- Pentamycetin Ophthalmic Solution 0.25%-Alendronate and cholecalciferol
- Pentamycetin Ophthalmic Solution 0.25%-Alendronate Effervescent Tablets
- Pentamycetin Ophthalmic Solution 0.25%-Alendronate Oral Solution
- Pentamycetin Ophthalmic Solution 0.25%-Alendronate Sodium